122 related articles for article (PubMed ID: 12715738)
1. For parents. Type 1 diabetes research. Balancing hope with realism.
Dinsmoor RS
Diabetes Self Manag; 2003; 20(2):87-8, 91-2, 95, 99-102. PubMed ID: 12715738
[No Abstract] [Full Text] [Related]
2. Diabetes drug update: how 4 new options stack up.
Taylor JR; Campbell KM
J Fam Pract; 2007 Mar; 56(3):207-15. PubMed ID: 17343811
[No Abstract] [Full Text] [Related]
3. Islet cell transplants. A new treatment could benefit some type 1 diabetics, but it's not a cure after all.
Health News; 2004 Sep; 10(9):8-9. PubMed ID: 15597445
[No Abstract] [Full Text] [Related]
4. Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.
Ryan GJ; Jobe LJ; Martin R
Clin Ther; 2005 Oct; 27(10):1500-12. PubMed ID: 16330288
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacotherapies for type 1 diabetes mellitus].
Maruyama T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():190-5. PubMed ID: 12386992
[No Abstract] [Full Text] [Related]
6. [Treatment of insulin-dependent diabetes: new therapeutics. Cellular replacement: facts and perspectives].
Oberholzer J
Bull Acad Natl Med; 2003; 187(7):1297-306. PubMed ID: 15146605
[TBL] [Abstract][Full Text] [Related]
7. Novel peptides under development for the treatment of type 1 and type 2 diabetes mellitus.
Baron AD; Kim D; Weyer C
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):63-82. PubMed ID: 12477297
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapies in diabetes mellitus type 1.
Gupta S
Med Clin North Am; 2012 May; 96(3):621-34, xi. PubMed ID: 22703858
[TBL] [Abstract][Full Text] [Related]
9. Pramlintide: FDA wants more.
Diabetes Obes Metab; 2001 Oct; 3(5):386. PubMed ID: 11710342
[No Abstract] [Full Text] [Related]
10. Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.
Toso C; Morel P; Bucher P; Mathe Z; Demuylder-Mischler S; Bosco D; Berney T; Oberholzer J; Shapiro J; Oberholzer J; Philippe J
Transplantation; 2003 Oct; 76(7):1133-4. PubMed ID: 14557767
[No Abstract] [Full Text] [Related]
11. New therapies for diabetes management.
Garg SK
Diabetes Technol Ther; 2013 Feb; 15 Suppl 1():S126-35. PubMed ID: 23441701
[No Abstract] [Full Text] [Related]
12. Optimizing treatment success with an amylin analogue.
Want LL
Diabetes Educ; 2008; 34 Suppl 1():11S-7S. PubMed ID: 18268001
[TBL] [Abstract][Full Text] [Related]
13. Future trends in diabetes management.
George CM
Nephrol Nurs J; 2009; 36(5):477-83. PubMed ID: 19856809
[TBL] [Abstract][Full Text] [Related]
14. [Technological advances in diabetology].
Moreau F; Ratheau L; Spizzo AH; Jeandidier N; Pinget M
Soins; 2012 May; (765):21-4. PubMed ID: 22730880
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes drug boom: is newer better?
Johns Hopkins Med Lett Health After 50; 2007 Aug; 19(6):3, 7. PubMed ID: 17712909
[No Abstract] [Full Text] [Related]
16. Diabetes basics. Exenatide and pramlintide. New meds on the block.
Griffin S; Borders J
Diabetes Self Manag; 2006; 23(4):74-6, 79. PubMed ID: 16888865
[No Abstract] [Full Text] [Related]
17. New insulins and other possible therapeutic approaches.
Johannesen J; Petersen KF; Berger M; Binder C
Diabetologia; 1997 Oct; 40 Suppl 3():B89-93. PubMed ID: 9345654
[No Abstract] [Full Text] [Related]
18. First in class. Two new diabetes drugs.
Koredella T
Diabetes Forecast; 2005 Aug; 58(8):35-6. PubMed ID: 16124101
[No Abstract] [Full Text] [Related]
19. Islet transplantation: progress and challenge.
Gaglia JL; Shapiro AM; Weir GC
Arch Med Res; 2005; 36(3):273-80. PubMed ID: 15925017
[TBL] [Abstract][Full Text] [Related]
20. Symlin up close. How people are benefiting from this injected drug.
Spake A
Diabetes Forecast; 2008 Mar; 61(3):50-1. PubMed ID: 18446978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
